During the past decade, Robley Rex VA Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robley Rex VA Medical Center" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "VA Office of Research and Development" with 3 trials sponsored, "Louisville VA Medical Center" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Brigham and Women's Hospital" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robley Rex VA Medical Center" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Rocky Mountain MIRECC for Suicide Prevention" with 1 trials as a collaborator and "US Department of Veterans Affairs" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Robley Rex VA Medical Center" are "Crohn's Disease" (4 trials), "Atrial Fibrillation" (2 trials), "Acute Pancreatitis" (1 trials), "Cardiovascular Disease" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "Robley Rex VA Medical Center" in a lesser frequency.

Most popular intervention types in "Robley Rex VA Medical Center" are "Drug" (11 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Mirikizumab" (3 trials), "Ustekinumab" (2 trials), "Apixaban" (1 trials) and "CAMS-G" (1 trials). Other intervention names were less common.

The vast majority of trials in "Robley Rex VA Medical Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Robley Rex VA Medical Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Robley Rex VA Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Robley Rex VA Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".